Poly(epsilon-caprolactone) nanocomposite scaffolds for tissue engineering: a brief overview

Area of Science:

• Biomaterials Science
• Polymer Chemistry
• Tissue Engineering

Background:

• Polycaprolactone (PCL) is a widely used bioresorbable polymer in biomaterials and drug delivery.
• Its excellent rheological and viscoelastic properties facilitate manufacturing of medical devices and implants.
• PCL offers a long degradation period, beneficial for applications requiring sustained kinetics, such as bone tissue engineering.

Purpose of the Study:

• To review advancements in polycaprolactone (PCL) polymeric systems for biological and tissue engineering.
• To highlight fabrication technologies for PCL-based scaffolds.

Main Methods:

• Literature review of polycaprolactone (PCL) applications in biomaterials and tissue engineering.
• Analysis of hybrid material development through nanofiller incorporation or polymer blending.
• Examination of scaffold fabrication techniques.

Main Results:

• Polycaprolactone (PCL) and its hybrid forms exhibit significantly improved properties like strength, porosity, and bioactivity.
• Hybrid materials allow for controllable degradation rates, crucial for tissue regeneration.
• Various fabrication technologies enhance the suitability of PCL scaffolds for tissue engineering.

Conclusions:

• Polycaprolactone (PCL) systems, especially hybrid materials, show great promise for diverse tissue engineering applications.
• Tailoring PCL properties through modifications and advanced fabrication techniques is key to their success.
• Further research into PCL-based scaffolds will drive innovation in regenerative medicine.